Results 81 to 90 of about 110,931 (189)

Long-term results of a randomized controlled trial of biosimilar CT-P16 and reference bevacizumab in patients with metastatic or recurrent non-small cell lung cancer

Cancer Treatment and Research Communications
Purpose: Data from the CT-P16 3.1 study demonstrated equivalent efficacy between CT-P16, a bevacizumab biosimilar, and European-approved reference bevacizumab (EU-bevacizumab) for the primary endpoint of objective response rate (ORR) during induction ...
Zoran Andric, Fedor Moiseenko, Tamta Makharadze, Alona Oleksiienko, Eduardo Yañez Ruiz, SungHyun Kim, KeumYoung Ahn, TaeHong Park, Hana Ju, Eric Hyungseok Baek, Soonbum Kwon, IlSung Chang, SinHye Kim, HyunAh Kim, EunKyung Lee, Claire Verschraegen   +15 more
doaj   +1 more source

Gastric Perforation Presenting as Empyema in a Patient with Pancreatic Cancer on Bevacizumab Treatment

, 2011
Bowel perforation is a rare but life-threatening complication of bevacizumab, a new anticancer treatment. Patients with bowel perforation usually present with acute abdominal symptoms.
邵幼雲;林宗哲;梁博欽;田郁文;鄭安理, SHAO, YU-YUN;LIN, ZONG-ZHE;LIANG, PO-CHIN;TIEN, YU-WEN;CHENG, ANN-LII   +1 more
core  

Using bevacizumab with different chemotherapeutic regimens in metastatic colorectal cancer: balancing utility with low toxicity

Therapeutic Advances in Medical Oncology, 2010
The addition of bevacizumab to currently available treatment options for metastatic colorectal cancer has changed the traditional chemotherapy-based paradigm.
G. Chong, N.C. Tebbutt
doaj   +1 more source

Acute anterior uveitis following intravitreal bevacizumab but not subsequent ranibizumab

, 2011
Christina Antonopoulos1, Maxwell Stem2, Grant M Comer21Department of Ophthalmology, Boston University, Boston, MA, USA; 2WK Kellogg Eye Center, Department of Ophthalmology, University of Michigan, Ann Arbor, MI, USAPurpose: Previous reports have ...
Antonopoulos C, Stem M, null Antonopoulos, Grant Comer, null Stem, Comer GM   +5 more
core   +1 more source

Intravitreal Bevacizumab and Panretinal Photocoagulation for Proliferative Diabetic Retinopathy Associated with Vitreous Hemorrhage

, 2011
Purpose: To evaluate the efficacy of intravitreal bevacizumab with panretinal photocoagulation (PRP) in the treatment of proliferate diabetic retinopathy (PDR) with vitreous hemorrhage (VH).
黃昱勳;葉伯廷;陳慕師;楊長豪;楊中美, HUANG, YU-HSUN;YEH, PO-TING;CHEN, MUH-SHY;YANG, CHANG-HAO;YANG, CHUNG-MAY   +1 more
core   +1 more source

Effect of bevacizumab (Avastin TM ) on mitochondrial function of in vitro retinal pigment epithelial, neurosensory retinal and microvascular endothelial cells

Indian Journal of Ophthalmology, 2013
Purpose: To evaluate the effect of bevacizumab on the mitochondrial function of human retinal pigment epithelial (ARPE-19), rat neurosensory retinal (R28) and human microvascular endothelial (HMVEC) cells in culture.
Saurabh Luthra, Ashish Sharma, Joyce Dong, Aneesh Neekhra, Ana L Gramajo, Gail M Seigel, M Cristina Kenney, Baruch D Kuppermann   +7 more
doaj   +1 more source

Monitoring antiangiogenesis of bevacizumab in zebrafish

, 2018
Jing Zhang,1,2,* Beili Gao,1,* Wenchao Zhang,1 Zijun Qian,1 Yi Xiang1 1Department of Respiratory and Critical Care Medicine, Ruijin Hospital, Institute of Respiratory Diseases, School of Medicine, Shanghai Jiaotong University, Shanghai, People’s ...
Gao BL, Qian ZJ, Zhang J, Zhang WC, Xiang Y   +4 more
core  

Bevacizumab-induced inhibition of scratch wound pterygium fibroblast migration and down-regulation of MMP-3 and MMP-13 expression.

, 2017
(A) Effects of bevacizumab (1 μg/ml) on cell migration were determined using a scratch wound assay and phase-contrast microscopy. Dashed lines indicate the precise location of the scratch wound. White scale bar: 50 μm.
Sang Il Gum (3625799), Yeoun-Hee Kim (1893997), Jae-Chang Jung (1893988), Jin Yeul Ma (299100), Young Jeung Park (3625802), Yong Il Kim (3625793), Su-Bin Park (3625796), Kyoo Won Lee (3625790)   +7 more
core   +1 more source

Time to full publication of studies of anti-cancer medicines for breast cancer, and the potential for publication bias: a short systematic review

, 2008
Objectives: To identify the expected delay between publication of conference abstracts and full publication of results from trials of new anti-cancer agents for breast cancer and to identify whether there are any apparent biases in publication and ...
Hartwell, D., A Takeda, E Loveman, D Hartwell, K Welch, Loveman, E., Harris, P., Welch, K., P Harris, Takeda, A.   +9 more
core   +1 more source

Intravitreal bevacizumab for delayed radiation maculopathy and papillopathy after irradiation for maxillary sinus cancer

, 2011
Miki Gondo1, Tsutomu Sakai1, Hiroshi Tsuneoka1, Chihiro Kanehira21Department of Ophthalmology, Jikei University School of Medicine, 2Division of Radiology, Jikei University School of Medicine, Tokyo, JapanBackground: The evaluation of intravitreal ...
Sakai T, Tsuneoka H, Tsutomu Sakai, Miki Gondo, Kanehira C, Hiroshi Tsuneoka, Chihiro Kanehira, Gondo M   +7 more
core   +1 more source